Renal and Intracranial Vasculopathy in an Adolescent with Neurofibromatosis Type 1: A Case Report

Main Article Content

Emily Patron Chi*
Veronica Leon Burgos

Abstract

BACKGROUND: Neurofibromatosis type 1 (NF1) is an autosomal dominant multisystem disorder characterized by variable clinical expression. Although cutaneous manifestations are the most recognizable features, NF1 may be associated with clinically significant vascular abnormalities involving multiple arterial territories. We report an adolescent with NF1 and concomitant renal and intracranial vasculopathy.


 


CASE PRESENTATION: A 15-year-old girl with no relevant family history presented with a 4-day history of severe frontal headache, vomiting, generalized weakness, and left eyelid ptosis. Physical examination revealed multiple café-au-lait macules and axillary and inguinal freckling, fulfilling the revised 2021 diagnostic criteria for NF1. During hospitalization, persistent hypertension was documented, with blood pressure values up to 180/90 mmHg. Complete blood count, liver function tests, serum electrolytes, and renal function remained within age- and sex-appropriate reference ranges. Renal angiography demonstrated approximately 80% proximal stenosis of the left renal artery followed by aneurysmal dilatation measuring 4 × 8 mm. The patient subsequently developed acute neurologic deterioration with intraventricular hemorrhage and ventriculomegaly. Cerebral angiography revealed a 13 × 15 mm saccular aneurysm of the left posterior communicating artery associated with complete ipsilateral third cranial nerve palsy. Coil embolization of the intracranial aneurysm and balloon angioplasty of the left renal artery were successfully performed, resulting in complete angiographic occlusion of the aneurysm and improved blood pressure control, although antihypertensive therapy remained necessary.


 


CONCLUSION: This case highlights the potential for NF1-associated vasculopathy to affect multiple arterial territories simultaneously. Difficult-to-control hypertension and new focal neurologic findings in patients with NF1 should prompt targeted vascular evaluation. Early recognition and multidisciplinary management are essential to identify potentially severe renal and intracranial vascular complications.

Article Details

How to Cite
Patron Chi*, Emily, and Veronica Leon Burgos. 2026. “Renal and Intracranial Vasculopathy in an Adolescent With Neurofibromatosis Type 1: A Case Report”. International Journal of Medical Science and Clinical Research Studies 6 (09):1918-25. https://doi.org/10.47191/ijmscrs/v6-i9-21.
Section
Articles

References

I. Peduto C, Zanobio M, Nigro V. Neurofibromatosis type 1: pediatric aspects and review of genotype–phenotype correlations. Cancers (Basel). 2023;15(4):1217. https://doi.org/10.3390/cancers15041217

II. Kehrer-Sawatzki H, Cooper DN. Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants. Hum Genet.2022;141(2):177-191. https://doi.org/10.1007/s00439-021-02410-z

III. Hernández-Castañeda Y, Juárez-Melchor D, Vera-Loaiza A, Pérez-Arzola AA, Crisanto-López IE, Rodríguez-Hurtado PO. Caracterización clínica de pacientes con síndrome neurocutáneo. Rev Med Inst Mex Seguro Soc.2025;63(2):e6419. https://doi.org/10.5281/zenodo.14616948

IV. Friedman JM. Neurofibromatosis 1. 1998 Oct 2 [updated 2025 Apr 3]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. https://www.ncbi.nlm.nih.gov/books/NBK1109/

V. Legius E, Messiaen L, Wolkenstein P, Pancza P, Avery RA, Berman Y, et al. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med.2021;23(8):1506-1513. https://doi.org/10.1038/s41436-021-01170-5

VI. Stewart DR, Korf BR, Nathanson KL, Stevenson DA, Yohay K. Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med.2018;20:671-682. https://doi.org/10.1038/gim.2018.28

VII. Zedde M, Pascarella R. Neurovascular issues in neurofibromatosis type I: focus on intracranial stenosis. Life (Basel).2026;16(2):234. https://doi.org/10.3390/life16020234

VIII. Beladan CC, Geavlete OD, Botezatu S, Postu M, Popescu BA, Ginghina C, et al. Revascularization in a 17-year-old girl with neurofibromatosis and severe hypertension caused by renal artery stenosis. Tex Heart Inst J. 2017;44(1):50-54. https://doi.org/10.14503/THIJ-15-5466

IX. Srinivasan A, Krishnamurthy G, Fontalvo-Herazo L, Nijs E, Keller MS, Meyers K, Kaplan B, Cahill AM. Angioplasty for renal artery stenosis in pediatric patients: an 11-year retrospective experience. J Vasc Interv Radiol. 2010;21(11):1672-1680. https://doi.org/10.1016/j.jvir.2010.07.012

X. Ueda K, Awazu M, Konishi Y, Takenouchi T, Shimozato S, Kosaki K, Takahashi T. Persistent hypertension despite successful dilation of a stenotic renal artery in a boy with neurofibromatosis type 1. Am J Med Genet A. 2013;161A(5):1154-1157. https://doi.org/10.1002/ajmg.a.35829

XI. Chillura I, Restivo GA, Callari S, Cibella S, D'Alessandro MM, Corrado C, Vallone M, Antona V, Corsello G. A novel NF1 mutation in a pediatric patient with renal artery aneurysm. Ital J Pediatr. 2022;48(1):186. https://doi.org/10.1186/s13052-022-01382-8

XII. AlSheikh S. Renal artery aneurysm induced by neurofibromatosis type 1: a case report and review of the endovascular interventions for this rare vasculopathy. Medicine (Baltimore). 2023;102(27):e34216. https://doi.org/10.1097/MD.0000000000034216

XIII. Sheerin UM, Holmes P, London NF1 Research Group, Childs L, Roy A, Ferner RE. Neurovascular complications in adults with neurofibromatosis type 1: a national referral center experience. Am J Med Genet A. 2022;188(10):3009-3015. https://doi.org/10.1002/ajmg.a.62931

XIV. Wala SJ, Beebe M, Warren P, Kallash M, Nathan J, Rasmussen S. Early experience with renal autotransplant for renal artery stenosis in a 6-year-old patient with neurofibromatosis type 1: a case report. J Med Case Rep. 2025;19(1):196. https://doi.org/10.1186/s13256-025-05208-z

XV. Dang QL, Fairman AS. Endovascular salvage of renal artery bypass in pediatric a patient with neurofibromatosis type 1. J Vasc Surg Cases Innov Tech. 2025;11(1):101644. https://doi.org/10.1016/j.jvscit.2024.101644

XVI. Pytlos J, Majcher P, Skrzypczyk P, Maciąg R, Werner B, Furmanek M. A complex case of renal artery stenosis in a 3-year-old patient with neurofibromatosis type 1 and secondary hypertension. Diagnostics (Basel). 2026;16(7):1047. https://doi.org/10.3390/diagnostics16071047